Neefjes JJ - Search Results

1

Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.

Souwer Y, Chamuleau ME, van de Loosdrecht AA, Tolosa E, Jorritsma T, Muris JJ, Dinnissen-van Poppel MJ, Snel SN, van de Corput L, Ossenkoppele GJ, Meijer CJ, Neefjes JJ, Marieke van Ham S. Souwer Y, et al. Among authors: neefjes jj. Br J Haematol. 2009 May;145(3):334-43. doi: 10.1111/j.1365-2141.2009.07625.x. Epub 2009 Feb 24. Br J Haematol. 2009. PMID: 19245431 Free article.

2

Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling.

Nijenhuis M, Calafat J, Kuijpers KC, Janssen H, de Haas M, Nordeng TW, Bakke O, Neefjes JJ. Nijenhuis M, et al. Among authors: neefjes jj. Eur J Immunol. 1994 Apr;24(4):873-83. doi: 10.1002/eji.1830240415. Eur J Immunol. 1994. PMID: 8149958

3

Antigen presentation by MHC class I and II molecules.

Neefjes JJ. Neefjes JJ. Immunobiology. 1996 Oct;195(4-5):456-60. doi: 10.1016/S0171-2985(96)80015-5. Immunobiology. 1996. PMID: 8933150 Review. No abstract available.

4

HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.

van Ham SM, Tjin EP, Lillemeier BF, Grüneberg U, van Meijgaarden KE, Pastoors L, Verwoerd D, Tulp A, Canas B, Rahman D, Ottenhoff TH, Pappin DJ, Trowsdale J, Neefjes J. van Ham SM, et al. Curr Biol. 1997 Dec 1;7(12):950-7. doi: 10.1016/s0960-9822(06)00414-3. Curr Biol. 1997. PMID: 9382849 Free article.

5

Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO.

van Ham M, van Lith M, Lillemeier B, Tjin E, Grüneberg U, Rahman D, Pastoors L, van Meijgaarden K, Roucard C, Trowsdale J, Ottenhoff T, Pappin D, Neefjes J. van Ham M, et al. J Exp Med. 2000 Apr 3;191(7):1127-36. doi: 10.1084/jem.191.7.1127. J Exp Med. 2000. PMID: 10748231 Free PMC article.

6

What to do with HLA-DO?

van Ham M, van Lith M, Griekspoor A, Neefjes J. van Ham M, et al. Immunogenetics. 2000 Aug;51(10):765-70. doi: 10.1007/s002510000208. Immunogenetics. 2000. PMID: 10970090 Review.

7

Novel polymorphisms in HLA-DOA and HLA-DOB in B-cell malignancies.

van Lith M, van Ham M, Neefjes J. van Lith M, et al. Immunogenetics. 2002 Nov;54(8):591-5. doi: 10.1007/s00251-002-0500-6. Epub 2002 Oct 9. Immunogenetics. 2002. PMID: 12439622

8

Stable expression of MHC class I heavy chain/HLA-DO complexes at the plasma membrane.

van Lith M, van Ham M, Neefjes J. van Lith M, et al. Eur J Immunol. 2003 May;33(5):1145-51. doi: 10.1002/eji.200323472. Eur J Immunol. 2003. PMID: 12731039 Free article.

9

Chaperoning antigen presentation by MHC class II molecules and their role in oncogenesis.

Marsman M, Jordens I, Griekspoor A, Neefjes J. Marsman M, et al. Adv Cancer Res. 2005;93:129-58. doi: 10.1016/S0065-230X(05)93004-2. Adv Cancer Res. 2005. PMID: 15797446 Review.

10

MHC class I alleles and their exploration of the antigen-processing machinery.

Groothuis TA, Griekspoor AC, Neijssen JJ, Herberts CA, Neefjes JJ. Groothuis TA, et al. Among authors: neefjes jj. Immunol Rev. 2005 Oct;207:60-76. doi: 10.1111/j.0105-2896.2005.00305.x. Immunol Rev. 2005. PMID: 16181327 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters